Cover Image

Accuracy of the QuantiFERON-TB Gold in Tube for diagnosing tuberculosis in a young pediatric population previously vaccinated with Bacille Calmette-Guerin

Objective: To evaluate the accuracy of an interferongamma release assay (QuantiFERON-TB Gold in Tube) for diagnosing Mycobacterium tuberculosis infection in a young pediatric population. Methods: 195 children previously vaccinated with BCG were evaluated, being 184 healthy individuals with no clinic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marcelo Genofre Vallada (Author), Thelma Suely Okay (Author), Gilda Maria B. Del Negro (Author), Claudio Amaral Antonio (Author), Lidia Yamamoto (Author), Sonia Regina T. S. Ramos (Author)
Format:	Book
Published:	Sociedade de Pediatria de São Paulo, 2014-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy
by: Chun-Yu Cheng, et al.
Published: (2015)

Seroconversion of QuantiFERON-TB Gold Test due to Mycobacterium marinum Infection in a Patient with Psoriasis Treated with Adalimumab
by: Grigorios Theodosiou, et al.
Published: (2024)

Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
by: Sara Debulpaep, et al.
Published: (2019)

Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
by: Michel Ntiri, BS, et al.
Published: (2022)

Predictors for a positive QuantiFERON-TB-Gold test in BCG-vaccinated adults with a positive tuberculin skin test
by: Harsh Chawla, et al.
Published: (2012)

The seroconversion rate of QuantiFERON-TB gold in-tube test in psoriatic patients receiving anti-interleukin-23 monoclonal antibodies
by: Yi-Wei Huang, et al.
Published: (2022)

Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting.
by: Modupe Amofa-Sekyi, et al.
Published: (2024)

Low rate of seroconversion analyzing QuantiFERON TB-gold testing in patients with psoriasis and hidradenitis suppurativa taking biologic therapy at an academic center in New York City
by: Apostolos Katsiaunis, BS, et al.
Published: (2024)

And what about the modified QuantiFERON test as a potential assay for early diagnosis of endometriosis?
by: Raffaella Mormile, et al.
Published: (2014)

Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test
by: Soni Parita MD, et al.
Published: (2017)

Lymphadenitis and lichen scofulosorum following bacille calmette-guérin vaccination in an infant
by: Taru Garg, et al.
Published: (2021)

Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia
by: Mohamed El-Helaly, et al.
Published: (2014)

Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants
by: AC Hesseling, et al.
Published: (2009)

Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran
by: Sadeghi-Shanbestari Mahnaz, et al.
Published: (2009)

Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study
by: Nuntana Chumpa, et al.
Published: (2022)

Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study.
by: Kamlesh Gidwani, et al.
Published: (2011)

Bacille-Calmette-Guérin vaccine-associated suppurative lymphadenitis in Hong Kong (China), 2004 to 2012
by: Man-ha Wong, et al.
Published: (2013)

Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials?
by: Asma Binte Aziz, et al.
Published: (2020)

Idiopathic granulomatous mastitis in a male breast following intravesical Bacille Calmette-Guerin treatment
by: Cennet Sahin, et al.
Published: (2020)

Multisystem inflammatory syndrome in children associated with Bacille Calmette-Guérin scar: a case presentation
by: Hilal Kizildag, et al.
Published: (2023)

Mycobacterial arthritis as a complication of a Bacille Calmette-Guérin (BCG) vaccination in an immunocompetent child
by: Dérfalvi B, et al.
Published: (2008)

The real-life number of neonatal doses of Bacille Calmette-Guérin vaccine in a 20-dose vial
by: Frederik Schaltz-Buchholzer, et al.
Published: (2017)

Comparison of the tuberculin skin test and Quanti-FERON-TB Gold In-Tube (QFT-G) test for the diagnosis of latent tuberculosis infection in dialysis patients
by: Hamdan Al Jahdali, et al.
Published: (2013)

Comparison study of QuantiFERON test with tuberculin skin testing to diagnose latent tuberculosis infection among nurses working in teaching hospitals of Ahvaz, Iran
by: Seyed-Mohammad Alavi, et al.
Published: (2016)

Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review
by: Joseph Christian Obnial, et al.
Published: (2022)

Booster Dose of Bacille Calmette-Guérin Vaccine for Tuberculosis in Low and Middle-Income Countries: A Systematic Review
by: Oduwole OA, et al.
Published: (2021)

Does bacille calmette-Guérin vaccination provides protection against COVID-19: A systematic review and meta-analysis
by: Daisy Khera, et al.
Published: (2021)

Bacille Calmette-Guérin Site Reactivation of Kawasaki Disease in Infants under 3 Months of Age: Relation with Diagnosis and Prognosis
by: Da Eun Roh, et al.
Published: (2022)

Acute tenosynovitis following an accidental injection of Bacille Calmette-Guérin (BCG) in a health care worker: A case report
by: Mieko Tokano, et al.
Published: (2024)

Regional Lymphadenitis Related to Bacille Calmette-Guerin Vaccination: A Case Series from a Tertiary Care Childrens' Hospital
by: Ekta Narang, et al.
Published: (2024)

The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model
by: Cameron D William, et al.
Published: (2006)

Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response
by: Areti Tychala, et al.
Published: (2021)

Revisiting Bacille Calmette‐Guérin revaccination strategies: timing of immunization, Mycobacterium tuberculosis and non‐tuberculous mycobacteria infections, strain potency and standardization of randomized controlled trials
by: Wenping Gong, et al.
Published: (2024)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
by: Dayoung Ko, et al.
Published: (2022)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
by: Rolandas Selvestravičius, et al.
Published: (2016)

Linfadenitis por vacuna de bacilo Calmette-Guérin
by: Armando Reyes-Cadena
Published: (2015)

The management and outcome of Bacillus Calmette-Guérin vaccine overdose
by: Sung-Hsi Wei, et al.
Published: (2018)

Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70
by: Fu-Ying Dai, et al.
Published: (2017)

Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk
by: Ugo Fedeli, et al.
Published: (2021)

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
by: Yun Peng, et al.
Published: (2024)